Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Soluble epoxide hydrolase inhibitors and cardiovascular diseases.

Wang ZH, Davis BB, Jiang DQ, Zhao TT, Xu DY. Soluble epoxide hydrolase inhibitors and cardiovascular diseases. Curr Vasc Pharmacol. 2013 Jan; 11(1):105-11.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.